NCT07275125Not yet recruiting
Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
Source: ClinicalTrials.gov · Last updated 10 Dec 2025
Brief summary (registry, in English)
To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points: 1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. Cognitive function by stanford binet intelligence scale 5th edition. 4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 28 Sept 2025
- Start date
- 30 Dec 2025
- Primary completion date
- 30 May 2026
- Lead sponsor
- Sohag University
- Diseases
- Epilepsy
- NCT number
- NCT07275125
What you commit to
- Study type: Observational
- Planned participants: 40
- From 30 Dec 2025 to the primary completion date, 30 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Non-compliance with KD .
- Patients on alternative dietary therapies (e.g., low glycemic diet)
Other illness
- \- Patients with contraindicated metabolic/genetic conditions.
Who the study is looking for
- Children aged 1-18 years.
- Diagnosed with drug-resistant epilepsy according to ILAE definition.\[2\]
- On KD for at least 6 months.
Age in the registry: 1 year to 18 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag faculty of medicine Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.